Joharatnam-Hogan, N., Cafferty, F., Hubner, R., Swinson, D., Sothi, S., Gupta, K., Falk, S., Patel, K., Warner, N., Kunene, V., Rowley, S., Khabra, K., Underwood, T., Jankowski, J., Bridgewater, J., Crossley, A., Henson, V., Berkman, L., Gilbert, D., Kynaston, H., Ring, A., Cameron, D., Din, F., Graham, J., Iveson, T., Adams, R., Thomas, A., Wilson, R., Pramesh, C. S., Langley, R., & , (2019). aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial. Lancet gastroenterology and hepatology, 4, 854–862. http://access.bl.uk/ark:/81055/vdc_100092796527.0x000003